Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001437782-26-000004

President and CEO sold 167,577 shares at an average $2.24 ($375,315)

  • President and CEO acquired 280,000 shares (grant or award)
  • President and CEO acquired 66,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Oliveto Joseph · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-12 Grant or award : show line 1 in the form +280,000 583,721 D
2025-12-15 Sale : show line 2 in the form −133,054 $2.32 $308,685 450,667 D
2026-01-26 Exercise or conversion : show line 3 in the form +66,600 517,267 D
2026-01-26 Sale : show line 4 in the form −34,523 $1.93 $66,629 482,744 D
Open-market sales · 167,577 sh · avg $2.24 · $375,315

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-12 Grant or award : show line 5 in the form Employee Stock Option (right to buy) +280,000 280,000 D
2026-01-26 Exercise or conversion : show line 6 in the form Restricted Stock Units −66,600 199,800 D
Loading xslF345X05/form4-01282026_060101.xml…